MYD88 and neoplasm: Moreover, despite being a target of TLR8 agonism, we did not see an increase in TLR8 signaling molecules (except MYD88 in dendritic cell populations) in post-treatment biopsies, possibly because of tumor resection timing (scRNAseq).